23.22
Privia Health Group Inc stock is traded at $23.22, with a volume of 1.08M.
It is up +1.53% in the last 24 hours and down -2.68% over the past month.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
See More
Previous Close:
$22.87
Open:
$22.85
24h Volume:
1.08M
Relative Volume:
1.49
Market Cap:
$2.86B
Revenue:
$1.80B
Net Income/Loss:
$15.62M
P/E Ratio:
193.50
EPS:
0.12
Net Cash Flow:
$118.36M
1W Performance:
-3.01%
1M Performance:
-2.68%
6M Performance:
+18.53%
1Y Performance:
+3.02%
Privia Health Group Inc Stock (PRVA) Company Profile
Name
Privia Health Group Inc
Sector
Industry
Phone
571-366-8850
Address
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
PRVA
Privia Health Group Inc
|
23.22 | 2.81B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
203.92 | 34.52B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
59.82 | 11.30B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
85.67 | 7.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.27 | 7.18B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
DOCS
Doximity Inc
|
37.47 | 7.27B | 550.17M | 201.35M | 232.07M | 1.00 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-09-26 | Initiated | RBC Capital Mkts | Outperform |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-16-24 | Initiated | Macquarie | Outperform |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Resumed | Jefferies | Buy |
| Feb-22-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-23 | Initiated | Evercore ISI | Outperform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Mar-10-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-03-23 | Initiated | Goldman | Buy |
| Dec-09-22 | Initiated | Stifel | Buy |
| Dec-08-22 | Initiated | UBS | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| May-03-22 | Initiated | BofA Securities | Buy |
| Apr-28-22 | Initiated | BTIG Research | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Feb-22-22 | Upgrade | Cowen | Market Perform → Outperform |
| Jan-03-22 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| May-24-21 | Initiated | Canaccord Genuity | Buy |
| May-24-21 | Initiated | Credit Suisse | Outperform |
| May-24-21 | Initiated | JP Morgan | Overweight |
| May-24-21 | Initiated | Piper Sandler | Overweight |
| May-24-21 | Initiated | Truist | Buy |
| May-24-21 | Initiated | William Blair | Outperform |
View All
Privia Health Group Inc Stock (PRVA) Latest News
How Investors May Respond To Privia Health Group (PRVA) After UnitedHealth’s Medicare Revenue Outlook Ripples - Yahoo Finance
Should UnitedHealth’s Medicare Outlook And Restructuring Require Action From Privia Health Group (PRVA) Investors? - simplywall.st
Why Privia Health (PRVA) Shares Are Plunging Today - TradingView
Privia Health Group, Inc. (PRVA) Stock Analysis: A Healthcare Innovator with 29.67% Upside Potential - DirectorsTalk Interviews
Analyzing Pulmonx (NASDAQ:LUNG) and Privia Health Group (NASDAQ:PRVA) - Defense World
Precision Trading with Privia Health Group Inc. (PRVA) Risk Zones - Stock Traders Daily
Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26 - The Manila Times
Take Care Before Diving Into The Deep End On Privia Health Group, Inc. (NASDAQ:PRVA) - simplywall.st
Privia Health Group, Inc.'s (NASDAQ:PRVA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Aug Chart Watch: Is Privia Health Group Inc stock overvalued or fairly pricedJuly 2025 Decliners & AI Driven Price Forecasts - baoquankhu1.vn
Privia Health Group Inc (PRVA) Trading 4.29% Higher on Jan 15 - GuruFocus
Buyback Watch: Does Privia Health Group Inc have strong EBITDA marginsJuly 2025 Reactions & Scalable Portfolio Growth Methods - baoquankhu1.vn
Earnings Miss: Why Privia Health Group Inc stock could be next big winner2025 Volume Leaders & High Conviction Trade Alerts - Bộ Nội Vụ
Technical Reactions to PRVA Trends in Macro Strategies - Stock Traders Daily
Robeco Institutional Asset Management B.V. Acquires Shares of 51,756 Privia Health Group, Inc. $PRVA - MarketBeat
Privia Health Group (NASDAQ:PRVA) Upgraded at Royal Bank Of Canada - Defense World
Privia Health Group (NASDAQ:PRVA) Raised to Moderate Buy at Royal Bank Of Canada - MarketBeat
Privia Health Group (NASDAQ:PRVA) Now Covered by Royal Bank Of Canada - Defense World
RBC Capital Reinstates Coverage of PRVA with "Outperform" Rating - GuruFocus
Royal Bank Of Canada Initiates Coverage on Privia Health Group (NASDAQ:PRVA) - MarketBeat
Will Privia Health Group Inc. stock recover faster than peers2025 Trading Recap & Consistent Profit Focused Trading Strategies - ulpravda.ru
Privia Health stock rating initiated at Outperform by RBC Capital - Investing.com South Africa
Privia Health stock rating initiated at Outperform by RBC Capital By Investing.com - Investing.com Nigeria
Is Privia Health Group Inc. stock a dividend growth opportunityEarnings Beat & Weekly Watchlist for Hot Stocks - ulpravda.ru
Can Privia Health Group Inc. stock attract ESG capital inflowsJuly 2025 Trends & Weekly Top Performers Watchlists - Улправда
Market Cool On Privia Health Group, Inc.'s (NASDAQ:PRVA) Revenues - 富途牛牛
Citizens reiterates Market Outperform rating on Privia Health stock By Investing.com - Investing.com South Africa
Citizens reiterates Market Outperform rating on Privia Health stock - Investing.com
Evolent Health (EVH) sells ACO unit, strengthens balance sheet - MSN
Privia Health Group Inc Stock Analysis and ForecastLow Beta Stocks & Free Superior Trading Gains - earlytimes.in
3 Stocks That May Be Trading Below Their Estimated Value - Sahm
Privia Health Group, Inc.'s (NASDAQ:PRVA) Stock Has Shown A Decent Performance: Have Financials A Role To Play? - 富途牛牛
Privia Health Group, Inc. $PRVA Shares Sold by Corient Private Wealth LLC - Defense World
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health - The Globe and Mail
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Privia Health Group Adjusts Valuation Amid Evolving Market Dynamics in Insurance Sector - Markets Mojo
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run - The Globe and Mail
Evolent Health (EVH) Sells ACO Unit, Strengthens Balance Sheet - Finviz
Riverbridge Partners LLC Has $115.38 Million Position in Privia Health Group, Inc. $PRVA - MarketBeat
Signal Recap: Why hedge funds are buying Privia Health Group Inc. stockJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - Улправда
Why hedge funds are buying Privia Health Group Inc. stock2025 EndofYear Setup & Risk Managed Investment Entry Signals - Улправда
Can Privia Health Group Inc. stock surprise with earnings upsideJuly 2025 Market Mood & Community Verified Watchlist Alerts - DonanımHaber
Q3 2025 Healthcare Technology Earnings Review: Revenue Beats & Stock PerformanceNews and Statistics - IndexBox
Privia Health Group Inc Stock (PRVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):